Method of treating an interleukin-11-associated or -mediated fibrotic disease or condition by administering an anti-interleukin-11 receptor subunit alpha (IL-11RA) antibody
US12365738B2 · kind B2 · utility
0Cited by
30References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 25, 2024 |
| Grant date | Jul 22, 2025 |
| Priority date | — |
| Expiry date | Sep 25, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are antibodies and antigen binding fragments thereof that bind to human interleukin-11 receptor subunit α (IL-11Rα) and related compositions, which may be used in any of a variety of therapeutic or diagnostic methods, including the treatment or diagnosis of cancers, inflammatory diseases, autoimmune diseases, and others.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.